{
  "id": 1683806,
  "title": "Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited.",
  "url": "https://urgent.news/2026/08/18/gilead-sciences-has-quietly-become-one-of-the-most-underrated",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-18T09:38:00.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/08/18/gilead-sciences-has-quietly-become-one-of-the-most/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "The company's HIV franchise is stronger than ever, and it's adding a stable of oncology drugs.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited.",
        "url": "https://urgent.news/2026/08/18/gilead-sciences-has-quietly-become-one-of-the-most-underrated-1685548",
        "published": "2026-08-18T09:58:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}